English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

Sos, M. L., Fischer, S., Ullrich, R., Peifer, M., Heuckmann, J. M., Koker, M., et al. (2009). Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. Proceedings of the National Academy of Sciences of the United States of America, 106, 18351-18356. doi:10.1073/pnas.0907325106.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Sos, Martin L.1, Author           
Fischer, Stefanie1, Author           
Ullrich, Roland2, Author           
Peifer, Martin1, Author           
Heuckmann, Johannes M.1, Author           
Koker, Mirjam1, Author           
Heynck, Stefanie1, Author           
Stueckrath, Isabel1, Author           
Weiss, Jonathan1, Author           
Fischer, Florian1, Author           
Michel, Kathrin1, Author           
Goel, Aviva3, Author
Regales, Lucia3, Author
Politi, Katerina A.3, Author
Perera, Samanthi3, Author
Getlik, Matthaeus3, Author
Heukamp, Lukas C.3, Author
Ansen, Sascha3, Author
Zander, Thomas2, Author           
Beroukhim, Rameen3, Author
Kashkar, Hamid3, AuthorShokat, Kevan M.3, AuthorSellers, William R.3, AuthorRauh, Daniel3, AuthorOrr, Christine3, AuthorHoeflich, Klaus P.3, AuthorFriedman, Lori3, AuthorWong, Kwok-Kin3, AuthorPao, William3, AuthorThomas, Roman K.1, Author            more..
Affiliations:
1Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656              
2Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149663              
31. Univ Cologne, Fac Med, D-50931 Cologne, Germany 2. Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA 3. Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA 4. Max Planck Soc, Chem Genom Ctr, D-44227 Dortmund, Germany 5. Univ Hosp Bonn Med Sch, Dept Pathol, D-53127 Bonn, Germany 6. Univ Cologne, Fac Med, Dept Internal Med, D-50924 Cologne, Germany 7. Univ Cologne, Fac Med, Ctr Integrated Oncol Cologne Bonn, D-50924 Cologne, Germany 8. Univ Cologne, Fac Med, Inst Med Microbiol Immunol & Hyg, D-50924 Cologne, Germany 9. Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA 02141 USA 10. Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA 11. Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA 12. Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA 13. Novartis Inst BioMed Res, Cambridge, MA 02139 USA 14. Genentech Inc, Dept Canc Signaling & Translat Oncol, San Francisco, CA 94070 USA 15. Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA 16. Harvard Univ, Sch Med, Boston, MA 02115 USA 17. Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA, ou_persistent22              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2009-10-27
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 572957
DOI: 10.1073/pnas.0907325106
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Proceedings of the National Academy of Sciences of the United States of America
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 106 Sequence Number: - Start / End Page: 18351 - 18356 Identifier: ISSN: 0027-8424